Having a Rhabdomyosarcoma is a serious condition, but there are some things you can do to help reduce your chances of developing it. Some of these things include making sure you exercise, eating right, and having an active lifestyle.
Treatment options
Depending on the type of rhabdomyosarcoma, treatment options can vary. Often, a combination of chemotherapy, radiation therapy, and surgery will be used to treat cancer. The side effects of these treatments may include bruising, fatigue, and decreased resistance to infection. Some patients may also need palliative care to manage the symptoms of the disease.
For treatment, doctors and parents work together to decide on the best course of treatment for the child. They will discuss the expected side effects and other goals of the treatment. In addition, the patient will be closely monitored.
The types of treatment options for rhabdomyosarcoma depend on the type of tumor, the stage of cancer, and the age of the patient. The size of the tumor and its location will also affect the prognosis. Cancer may be diagnosed in the head and neck, bladder, or bowel.
The initial diagnosis of rhabdomyosarcoma should be made by an experienced pediatric pathologist. A biopsy is taken to determine the anatomic location of the tumor and its stage. The sample will then be examined in a laboratory. X-rays are also performed. The X-rays will help the doctor to detect the lumps inside the organs.
The chemotherapy that is prescribed for the child will depend on the size of the tumor and the type of rhabdomyosarcoma. The chemotherapy is usually given in a vein. The side effects of the chemotherapy will vary depending on the type and dosage of the drugs. Some of the common side effects of chemotherapy are nausea, vomiting, diarrhea, and bone marrow suppression.
Etiology
Embryonal rhabdomyosarcoma is a malignant neoplasm that originates from primitive mesenchymal cells. These cells have a round shape with rich, thick filaments and an eccentric granular cytoplasm. They are arranged in large nests and have a myxoid matrix.
Embryonal rhabdomyosarcoma may arise in any part of the body. They are most commonly diagnosed in children below 15 years of age. However, they are also seen in adults. They have a distinctive pathophysiology and are therefore different from other soft tissue sarcomas.
There are two major subtypes of embryonal rhabdomyosarcoma: spindle/sclerosing and pleomorphic. Although both subtypes have similar gross characteristics, they are driven by fundamentally different molecular mechanisms. In addition, they pose significant clinical challenges.
Research has shown that age is a strong risk factor for the development of sarcomas. It has been reported that the incidence of sarcoma increases with the age of the child, with the highest rate being found in young children. Several epidemiologic studies have attempted to determine which risk factors are associated with sarcoma development.
The majority of studies have involved case-control studies. These studies use a wide range of exposures and cover infants and adolescents and include both in-utero and postnatal exposures. The study’s results have been largely consistent, indicating that maternal age is an important risk factor.
Another study investigated the relationship between etiology and clinical factors. They reported that the risk for rhabdomyosarcoma increased with the age of the mother. They also reported that the risk increased for children born to mothers who had experienced an overdue delivery or had been given antibiotics before birth.
Signs and symptoms
Whether you’re a parent of a child with rhabdomyosarcoma or just curious about the disease, you’ll want to learn all you can about the signs and symptoms of this type of cancer. It’s important to understand what can be expected, and how treatment can help. A rhabdomyosarcoma support community can be extremely helpful.
Rhabdomyosarcoma is a form of cancer that develops in the skeletal muscles, which help to move the body. This cancer usually begins in the mesenchymal cells, which are part of the muscle tissue. As the cells grow, they become mutated, causing a tumor to form.
The signs and symptoms of RMS vary depending on the location of the tumor, its size, and its stage of development. A tumor in the ear may cause a headache, and one in the head and neck area can cause swelling around the eyes, a bulging eye, and pain. The bladder and bowel can also be affected by these types of tumors. Several of these types of tumors can also cause blood to form in the urine.
In most cases, the disease is treated with surgery and chemotherapy. The purpose of surgery is to remove as much of the tumor as possible. If cancer has spread to other areas of the body, the doctor may need to do another surgery. Other treatments, such as radiation therapy, may also be used.
Sarcomas can occur anywhere in the body, but they are particularly common in the bone and soft tissues. They’re distinct from carcinomas, which are cancers that arise from the lining of the lung, pancreas, and other organs.
Neoadjuvant chemotherapy
Depending on the location and type of rhabdomyosarcoma, a child’s treatment can involve chemotherapy, surgery, and radiation therapy. This is why it is important to discuss treatment expectations with your doctor. Some children may need special activities or extra services to help them with their treatment. These may include child life specialists, physical therapists, and counselors.
Neoadjuvant chemotherapy for rhabdomyosarcoma involves using drugs before the main treatment to shrink the tumor. These include dactinomycin, cyclophosphamide, and vincristine.
Before chemotherapy, the doctor will usually use diagnostic tests to determine the stage of the rhabdomyosarcoma. This will allow the doctors to plan the treatment. For example, if cancer has spread to the lymph nodes, a sentinel lymph node biopsy will be performed. This will also help the doctors know if cancer has reached a recurrence site.
If cancer has not recurred, the treatment plan will usually involve surgery. If the rhabdomyosarcoma has recurred, the doctor will plan treatment that includes chemotherapy. These treatments can involve tyrosine kinase inhibitors, such as cabozantinib-s-malate, and sirolimus. These drugs block signals that cancer cells need to grow.
Chemotherapy can be given before or after surgery. It can cause side effects, including nausea, hair loss, and bone marrow suppression. It can also affect the kidneys. The side effects will depend on the drug used.
A child’s treatment will depend on the type of rhabdomyosarcoma, the child’s age and rhabdomyosarcoma risk, and the family’s preferences. The doctor will work with the parents to choose the best treatment for the child.
Radiation therapy
Currently, the standard treatment for pediatric rhabdomyosarcoma is surgery followed by chemotherapy. This therapy is often accompanied by other types of treatment, such as radiation therapy. The treatment plan depends on the type of tumor, stage of disease, previous treatment, and possible side effects. In some cases, children with rhabdomyosarcoma require intensive chemotherapy, which may lead to permanent infertility.
Pediatric sarcomas are a specific group of pathologies that arise from growing tissues or organs. They are often found adjacent to critical structures, such as the bones of the skull or spinal cord.
Pediatric sarcomas have approximately 900 new cases in the United States every year. They are also highly associated with genetic syndromes, such as Li-Fraumeni syndrome. In some cases, a child’s relative with cancer is also at higher risk for developing rhabdomyosarcoma.
Rhabdomyosarcomas are classified into three categories based on their location. These include low-risk, intermediate-risk, and high-risk. Patients in the high-risk category require radiation therapy, while those in the low-risk category do not.
Radiation therapy is most often used in the adjuvant setting. In this approach, radiation is given after surgical removal of the primary tumor and after chemotherapy. The doses of radiation range from a few thousand Gy to several hundred Gy, and are usually given to tumors less than five centimeters in diameter. It has been shown to be most effective in this setting.
In addition to surgery and chemotherapy, some rhabdomyosarcomas can be treated with dendritic cell immunotherapy. This approach has been shown to be effective for a variety of pediatric malignancies.
Anaplastic rhabdomyosarcoma
Among soft tissue sarcomas, rhabdomyosarcoma is the most common. Most cases are diagnosed in children under 10 years of age. It occurs most often in the neck, trunk, and extremities. It can also occur in the pelvic area and in the urinary tract. The symptoms include weight loss, pain, and weakness. Depending on the type of RMS involved, survival rates range from 5 to 7 years.
There are four histological subtypes of rhabdomyosarcoma. These are embryonal, pleomorphic, alveolar, and spindle cell/sclerosing. A child with one of these subtypes should be evaluated by a pediatric oncologist.
Embryonal rhabdomyosarcoma accounts for 70% to 75% of childhood sarcomas. It is characterized by a high frequency of mutations in genes involved in the RAS pathway. The cytoplasm of this tumor is hyperchromatic, and the nuclei are irregular. The fibroconnective tissue is infiltrated with lymphoplasmacytic cells. This form of rhabdomyosarcoma has been associated with a high risk of in-transit metastases.
In addition to age and gender, there are several other risk factors for rhabdomyosarcoma. Younger children are more likely to develop this disease, as are those with a family history of cancer. Some studies link birth weight and X-ray radiation in the womb to an elevated risk. A genetic syndrome known as Li-Fraumeni syndrome has been linked to a higher risk of rhabdomyosarcoma.
The World Health Organization (WHO) classification distinguishes four histological subtypes of sarcoma. The embryonal subtype is the most common. Embryonal rhabdomyosarcoma may occur at any primary site, but it is most common in the head and neck.
Health Sources:
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/
